St Mary's Hospital is an NHS hospital in Paddington, in the City of Westminster, London, founded in 1845.

During the past decade, St Mary's Hospital conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 33 clinical trials were completed, i.e. on average, 46.5% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 23 clinical trials were completed. i.e. 95.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Mary's Hospital" #1 sponsor was "Imperial College London" with 38 trials, followed by "Imperial College Healthcare NHS Trust" with 6 trials sponsored, "InSightec" with 6 trials sponsored, "Gilead Sciences" with 5 trials sponsored and "PENTA Foundation" with 5 trials sponsored. Other sponsors include 86 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Mary's Hospital" #1 collaborator was "Gilead Sciences" with 5 trials as a collaborator, "Imperial College London" with 4 trials as a collaborator, "Medical Research Council" with 4 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 4 trials as a collaborator and "University College, London" with 4 trials as a collaborator. Other collaborators include 79 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "St Mary's Hospital" are "HIV Infections" (12 trials), "HIV" (7 trials), "Prostate Cancer" (6 trials), "HIV Infection" (5 trials) and "Abdominal Aortic Aneurysm" (4 trials). Many other conditions were trialed in "St Mary's Hospital" in a lesser frequency.

Most popular intervention types in "St Mary's Hospital" are "Drug" (68 trials), "Device" (33 trials), "Other" (26 trials), "Procedure" (18 trials) and "Biological" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Filgotinib" (4 trials), "capecitabine" (4 trials), "fluorouracil" (4 trials) and "cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "St Mary's Hospital" are 125 trials for "All" genders, 14 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "St Mary's Hospital". undefined are not yet recruiting, 16 are recruiting, 16 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 77 completed trials in St Mary's Hospital, 1 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in St Mary's Hospital, 10 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 29 trials that are defined as “Not Applicable".